Serial #79297105
LIVE

Serial Number

79297105

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Jul 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79297105 Trademark

Serial Number: 79297105 • Registration: 6367054

Serial #79297105 is a trademark filed by Novartis AG on July 10, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

July 10, 2020

Registration Date

June 1, 2021

Published for Opposition

March 16, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 1, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 11, 2021 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Sep 23, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 23, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 1, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 1, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 16, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 16, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 15, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 24, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 11, 2021 CNSA
REFUSAL PROCESSED BY IB
Jan 30, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 8, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jan 8, 2021 RFRR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 6, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 4, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 4, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 4, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 4, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 4, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 4, 2021 COAR
APPLICATION FILING RECEIPT MAILED
Dec 25, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 24, 2020 RFCR
NON-FINAL ACTION WRITTEN
Dec 23, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 21, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 21, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 19, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 29, 2020 REPR